Cover Image

Association of Baldness with Coronary Artery Disease and Its Severity

Reza Arefi, Mehdi Pishgahi, Adel Joharimoghaddam, Mohammad Ali Momeni, Mehran Khoshfetrat
Background: The pivotal role of baldness as a potential risk factor for cardiovascular disorders remains a debate, and the small body of literature has generated inconsistent findings. We aimed to assess the association between baldness and the risk for coronary artery disease (CAD) and its severity in a sample of Iranian men. Materials and Methods: This cross-sectional study was performed on 105 consecutive patients suspected to CAD and scheduled for elective coronary angiography. The severity of CAD was determined according to the number of involved coronary vessels. For assessing the severity of baldness, the Hamilton-Norwood scale for grading of androgenetic alopecia in males was used. Results: The overall frequency of CAD in the groups with and without baldness was 88.9% and 72.5%, respectively, indicating a significant difference (P=0.033). Similarly, patients with the family history of baldness suffered more from CAD as compared to those without history (93.3% vs.76.0%). However, no significant association was found between the baldness and non-baldness groups with regard to the severity of CAD (P=0.291). According to the multivariable logistic regression model, the presence of baldness could predict the increased likelihood of CAD (or=3.037, P=0.046). Conclusion: Along with traditional risk factors for CAD, the presence of baldness and positive family history of this phenotype could be considered as the primary determinant for the increasing likelihood of CAD. [GMJ.2020;9:e1474]
Coronary Artery Disease; Baldness; Alopecia

Canto JG, Kiefe CI, Rogers WJ. NRMI Investigators. Number of coronary heart disease risk factors and mortality in patients with first myocardial infarction. JAMA. 2011;306(19):2120-7.

PMid:22089719 PMCid:PMC4494683

Yayan J. Association of traditional risk factors with coronary artery disease in nonagenarians: the primary role of hypertension. Clin Interv Aging. 2014;20;9:2003-12.

PMid:25429212 PMCid:PMC4242066

Zengin E, Bickel C, Schnabel RB, Zeller T, Lackner KJ, Rupprecht HJ, et al. Risk Factors of Coronary Artery Disease in Secondary Prevention--Results from the AtheroGene--Study. PLoS One. 2015;8;10(7):e0131434.

PMid:26154343 PMCid:PMC4496051

Arefi R, Namazi MH, Safi M, Saadat H, Vakili H, Pishgahi M, et al. Value of Transverse Groove on the Earlobe and Hair Growth on the Ear to Predict the Risk for Coronary Artery Disease and Its Severity among Iranian Population, in Tehran City. GMJ.2020;9: e1443

Gopinath H, Upadya GM. Metabolic syndrome in androgenic alopecia. Indian J Dermatol Venereol Leprol. 2016;82(4):404-8.


Banger HS, Malhotra SK, Singh S, Mahajan M. Is Early Onset Androgenic Alopecia a Marker of Metabolic Syndrome and Carotid Artery Atherosclerosis in Young Indian Male Patients? Int J Trichology. 2015;7(4):141-7.

PMid:26903742 PMCid:PMC4738480

Lee S, Lee H, Lee CH, Lee WS. Comorbidities in alopecia areata: A systematic review and meta-analysis. J Am Acad Dermatol. 2019;80(2):466-77.e16.


Cotton SG, Nixon JM, Carpenter RG, Evans DW. Factors discriminating men with coronary heart disease from healthy controls. Br Heart J. 1972; 34(5):458-64.

PMid:5031636 PMCid:PMC486958

Ford ES, Freedman DS, Byers T. Baldness and ischemic heart disease in a national sample of men. Am J Epidemiol. 1996; 143(7):651-7.


Lesko SM, Rosenberg L, Shapiro S. A case-control study of baldness in relation to myocardial infarction in men. JAMA.1993;269:998-1003.


Herrera CR, D'Agostino RB, Gerstman BB, Bosco LA, Belanger AJ. Baldness and coronary heart disease rates in men from the Framingham Study. Am J Epidemiol. 1995; 142(8):828-33.


Patil VB, Lunge SB. A study of correlation of angiographic evaluation of coronary artery disease with androgenetic alopecia-TricoHeart study. Int J Trichology. 2019; 11(6): 227-31.

PMid:32030055 PMCid:PMC6984045

Sharma L, Dubey A, Gupta PR, Agrawal A. Androgenetic alopecia and risk of coronary artery disease. Indian Dermatol Online J. 2013;4(4):283-7.

PMid:24350006 PMCid:PMC3853891

Shahar E, Heiss G, Rosamond WD, Szklo M. Baldness and myocardial infarction in men: the atherosclerosis risk in communities study. Am J Epidemiol.2015;167(6):676-83.


Gupta M, Mysore V. Classifications of patterned hair loss: a review. J Cutan Aesthet Surg. 2016;9(1):3.

PMid:27081243 PMCid:PMC4812885

/Sari I, Aykent K, Davutoglu V, Yuce M, Ozer O, Kaplan M, et al. Association of male pattern baldness with angiographic coronaryartery disease severity and collateral development. Neth Heart J. 2015;23(5):265-74.

PMid:25911010 PMCid:PMC4409596

Rebora A. Baldness and coronary artery disease: the dermatologic point of view of a controversial issue. Arch Dermatol. 2001; 137(7):943-7.

Mansouri P, Mortazavi M, Eslami M, Mazinani M. Androgenetic alopecia and coronary artery disease in women. Dermatol Online J. 2005;11(3):2.

Mumcuoglu C, Ekmekci TR, Ucak S. The investigation of insulin resistance and metabolic syndrome in male patients with early-onset androgenetic alopecia. Eur J Dermatol 2011; 21(1):79-82.


Su LH, Chen TH. Association of androgenetic alopecia with metabolic syndrome in men: a community-based survey. Br J Dermatol 2010;163(2):371-7.


Ahouansou S, Le Toumelin P, Crickx B. Association of androgenetic alopecia and hypertension. Eur J Dermatol. 2007;17(3):220-2.

Drabsch T, Holzapfel C, Stecher L, Petzold J, Skurk T, Hauner H. Associations between C-reactive protein, insulin sensitivity, and resting metabolic rate in adults: A mediator analysis. Front Endocrinol. 2018; 9: 556.

PMid:30294302 PMCid:PMC6158372

Hirsso P, Rajala U, Hiltunen L. Obesity and low-grade inflammation among young Finnish men with early-onset alopecia. Dermatology. 2007;214(2):125-9.


Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation. 2003; 28;107(3):363-9.


Al Edwan G, Bhindi B, Margel D, Chadwick K, Finelli A, Zlotta A, et al. The association of male pattern baldness and risk of cancer and high-grade disease among men presenting for prostate biopsy. Can Urol Assoc J. 2016;10(11-12):E424.

PMid:28096933 PMCid:PMC5167604


  • There are currently no refbacks.